📣 VC round data is live. Check it out!
- Public Comps
- Surgery Partners
Surgery Partners Valuation Multiples
Discover revenue and EBITDA valuation multiples for Surgery Partners and similar public comparables like Akdital, Pediatrix, Astrana Health, Siloam Hospitals and more.
Surgery Partners Overview
About Surgery Partners
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
Founded
2015
HQ

Employees
15.0K
Website
Sectors
Financials (LTM)
EV
$6B
Valuation Multiples
Start free trialSurgery Partners Financials
Surgery Partners reported last 12-month revenue of $3B and EBITDA of $528M.
In the same LTM period, Surgery Partners generated $1B in gross profit, $528M in EBITDA, and $59M in net income.
Revenue (LTM)
Surgery Partners P&L
In the most recent fiscal year, Surgery Partners reported revenue of $3B and EBITDA of $566M.
Surgery Partners is profitable as of last fiscal year, with gross margin of 23%, EBITDA margin of 17%, and net margin of 2%.
Financial data powered by Morningstar, Inc.
Surgery Partners Stock Performance
Surgery Partners has current market cap of $2B, and enterprise value of $6B.
Market Cap Evolution
Surgery Partners' stock price is $13.95.
Surgery Partners share price decreased by 0.5% in the last 30 days, and by 40.9% in the last year.
Surgery Partners has an EPS (earnings per share) of $0.46.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6B | $2B | -3.6% | -0.5% | -10.0% | -40.9% | $0.46 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSurgery Partners Valuation Multiples
Surgery Partners trades at 1.7x EV/Revenue multiple, and 10.7x EV/EBITDA.
EV / Revenue (LTM)
Surgery Partners Financial Valuation Multiples
As of May 17, 2026, Surgery Partners has market cap of $2B and EV of $6B.
Surgery Partners has a P/E ratio of 30.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Surgery Partners Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Surgery Partners Margins & Growth Rates
Surgery Partners grew revenue by 3% but EBITDA decreased by 6% in the last fiscal year.
In the most recent fiscal year, Surgery Partners reported gross margin of 23%, EBITDA margin of 17%, and net margin of 2%.
Surgery Partners Margins
Surgery Partners Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Surgery Partners Operational KPIs
Surgery Partners' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Surgery Partners' Rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Surgery Partners' Rule of X is 23% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Surgery Partners Competitors
Surgery Partners competitors include Akdital, Pediatrix, Astrana Health, Siloam Hospitals, OdontoPrev, MLP Sağlık, Draegerwerk, Select Medical, Huaxia Eye Hospital Group and Dr Agarwals.
Most Surgery Partners public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 4.4x | 3.6x | 15.0x | 12.4x | |||
| 1.1x | 1.1x | 7.8x | 7.7x | |||
| 0.8x | 0.7x | 12.1x | 10.9x | |||
| 2.4x | 2.4x | 9.9x | 9.6x | |||
| — | 3.3x | — | 10.4x | |||
| 1.8x | 1.6x | 5.5x | 5.8x | |||
| 0.4x | 0.4x | 3.6x | 3.6x | |||
| 0.9x | 0.9x | 9.4x | 9.9x | |||
This data is available for Pro users. Sign up to see all Surgery Partners competitors and their valuation data. Start Free Trial | ||||||
Surgery Partners M&A Activity
Surgery Partners has acquired 5 companies to date.
Last acquisition by Surgery Partners was on March 3rd 2026. Surgery Partners acquired Preferred Vascular Group for undisclosed valuation.
Latest Acquisitions by Surgery Partners
| Description | Preferred Vascular Group delivers vascular procedures such as phlebectomy, angiography, angioplasty, atherectomy, endovenous laser treatment, sclerotherapy, and thrombectomy. | National Surgical Healthcare is an owner and operator of short-stay surgical hospitals and ambulatory surgery centers across 12 U.S. states. Formed in 1998, the company partners with physicians on facilities specializing in orthopedics, spine, pain management, and cardiology. Backed by Irving Place Capital since 2011, National Surgical Healthcare focuses on high-acuity procedures in markets like Nashville, Tennessee, and Nashville, Tennessee. | Riverside Pain Physicians is a pain management clinic based in New Port Richey, Florida. The practice treats acute and chronic conditions using epidural injections, spinal cord stimulation, radiofrequency ablation, and medication management. Board-certified physicians serve patients from Tampa Bay area hospitals including HCA Florida Trinity Hospital, focusing on interventional procedures in accredited facilities. | — | |
| HQ Country | |||||
| HQ City | Atlanta, GA | Chicago, IL | Jacksonville, FL | Newark, NJ | |
| Deal Date | 3 Mar 2026 | 10 May 2017 | 14 Jun 2016 | 3 Feb 2015 | |
| Valuation | undisclosed | $760M | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Surgery Partners acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Surgery Partners
| When was Surgery Partners founded? | Surgery Partners was founded in 2015. |
| Where is Surgery Partners headquartered? | Surgery Partners is headquartered in United States. |
| How many employees does Surgery Partners have? | As of today, Surgery Partners has over 15K employees. |
| Who is the CEO of Surgery Partners? | Surgery Partners' CEO is J. Eric Evans. |
| Is Surgery Partners publicly listed? | Yes, Surgery Partners is a public company listed on Nasdaq. |
| What is the stock symbol of Surgery Partners? | Surgery Partners trades under SGRY ticker. |
| When did Surgery Partners go public? | Surgery Partners went public in 2015. |
| Who are competitors of Surgery Partners? | Surgery Partners main competitors include Akdital, Pediatrix, Astrana Health, Siloam Hospitals, OdontoPrev, MLP Sağlık, Draegerwerk, Select Medical, Huaxia Eye Hospital Group, Dr Agarwals. |
| What is the current market cap of Surgery Partners? | Surgery Partners' current market cap is $2B. |
| What is the current revenue of Surgery Partners? | Surgery Partners' last 12 months revenue is $3B. |
| What is the current revenue growth of Surgery Partners? | Surgery Partners revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Surgery Partners? | Current revenue multiple of Surgery Partners is 1.7x. |
| Is Surgery Partners profitable? | Yes, Surgery Partners is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Surgery Partners? | Surgery Partners' last 12 months EBITDA is $528M. |
| What is Surgery Partners' EBITDA margin? | Surgery Partners' last 12 months EBITDA margin is 16%. |
| What is the current EV/EBITDA multiple of Surgery Partners? | Current EBITDA multiple of Surgery Partners is 10.7x. |
| What is the current FCF of Surgery Partners? | Surgery Partners' last 12 months FCF is $163M. |
| What is Surgery Partners' FCF margin? | Surgery Partners' last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Surgery Partners? | Current FCF multiple of Surgery Partners is 34.7x. |
| How many companies Surgery Partners has acquired to date? | As of May 2026, Surgery Partners has acquired 5 companies. |
| What was the largest acquisition by Surgery Partners? | $792M acquisition of Symbion Holdings on 16th June 2014 was the largest M&A Surgery Partners has done to date. |
| What companies Surgery Partners acquired? | Surgery Partners acquired Symbion Holdings, National Surgical Healthcare, Preferred Vascular Group, Riverside Pain Physicians, and Delaware Outpatient Center for Surgery. |
| In how many companies Surgery Partners has invested to date? | Surgery Partners hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Surgery Partners
Lists including Surgery Partners
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
